By Rich Haridy June 19, 2022 The new data reports nearly 100 percent success in 75 patients treated with efficacy persisting up to three years beyond the initial treatment Depositphotos Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up...
Heidi Ledford The CRISPR–Cas9 complex (white and blue) can cut DNA (green), disabling genes that cause disease.Credit: Ella Maru Studio/Science Photo Library Preliminary results from a landmark clinical trial suggest that CRISPR–Cas9 gene-editing can be deployed directly into the body to treat disease. The study is the first to show that the technique can be...
